Abstract
Arteriovenous carbon dioxide removal (AVCO2R) by a low-resistance gas exchanger in a simple arteriovenous shunt is capable of achieving near total CO2 removal and lung rest during ARDS. We evaluated AVCO2R effect on a LD50 smoke/burn (36 breath, 40% III° TBSA) ARDS model in a prospective, randomized, controlled, unblinded 7-day outcomes study of ventilator free days and survival. All AVCO2R sheep survived, while only 2 SHAM animals survived the 7-day study. AVCO2R had 2.4 ventilator dependent days versus 6.5 days with SHAM. Four our initial patient experience, 5 adults in unresponsive, severe ARDS were successfully cannulated for AVCO2R at bedside and completed the 72-h trial and 3/5 patients were discharged. AVCO2R removed approximately 70% of CO2. Changes in ventilator parameters from baseline to 48 h included a decrease in tidal volume, peak inspiratory pressure, minute ventilation, and respiratory rate. Next, a before-after study of AVCO2R was performed on 8 subjects with ARDS. PaCO2 decreased significantly despite a decrease in minute ventilation from baseline and normalization of pH. We propose the normalization of CO2 and decreased minute ventilation allows amelioration of the pathophysiology of ARDS.
Original language | English (US) |
---|---|
Pages (from-to) | 1579-1580 |
Number of pages | 2 |
Journal | Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings |
Volume | 2 |
State | Published - 2002 |
Externally published | Yes |
Event | Proceedings of the 2002 IEEE Engineering in Medicine and Biology 24th Annual Conference and the 2002 Fall Meeting of the Biomedical Engineering Society (BMES / EMBS) - Houston, TX, United States Duration: Oct 23 2002 → Oct 26 2002 |
Keywords
- ARDS
- Arteriovenous CO removal
- Mechanical ventilation
ASJC Scopus subject areas
- Signal Processing
- Biomedical Engineering
- Computer Vision and Pattern Recognition
- Health Informatics